Saeki, T., Araki, K., Shimada, K., Shigekawa, T., Nakayama, H., Segawa, Y., & Mukai, H. (2016). Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. Int Cancer Conf J.

Saeki, Toshiaki, Kazuhiro Araki, Ken Shimada, Takashi Shigekawa, Hirofumi Nakayama, Yoshihiko Segawa, a Hirofumi Mukai. "Long-term Combination Chemotherapy Using Eribulin and Trastuzumab for Three Patients With Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer." Int Cancer Conf J 2016.

Saeki, Toshiaki, et al. "Long-term Combination Chemotherapy Using Eribulin and Trastuzumab for Three Patients With Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer." Int Cancer Conf J 2016.